| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
21,294,422 |
|
|
Indirect Shares
|
61,163,251 |
|
|
| Direct
Value |
$185,966,472 |
|
|
|
Indirect Value
|
$184,253,502 |
|
|
| Total
Shares |
82,457,673 |
|
|
| Total
Value |
$370,219,974 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
63
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
2
|
63
|
| |
|
|
|
Gain/Loss Ratio : |
-2.0
|
-63.0
|
| Percentage
Gain/Loss : |
 -70.1%
|
-4,048.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-06-28 |
20,225 |
2024-06-28 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2024-07-09 |
6,536 |
2024-07-09 |
1,912,156 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
637 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 20 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HNSN |
Hansen Medical Inc |
Director |
– • – |
2013-08-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
9,505,546 |
|
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-05-18 |
4 |
S |
$1.03 |
$42,456 |
I/I |
(41,195) |
9,707,848 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-05-05 |
4 |
S |
$1.14 |
$283,149 |
I/I |
(248,115) |
9,749,043 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-05-02 |
4 |
OE |
$16.80 |
$9,868,337 |
I/I |
587,401 |
9,776,920 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-04-30 |
4 |
S |
$1.25 |
$7,031 |
I/I |
(5,625) |
9,997,158 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-04-28 |
4 |
S |
$1.26 |
$101,065 |
I/I |
(80,498) |
10,002,783 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-04-09 |
4 |
S |
$1.20 |
$300,425 |
I/I |
(250,000) |
10,083,281 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-04-08 |
4 |
S |
$1.21 |
$300,800 |
I/I |
(248,636) |
10,333,281 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-02-25 |
4 |
S |
$2.71 |
$542 |
I/I |
(200) |
10,581,917 |
0 |
- |
|
| SLNO |
Soleno Therapeutics Inc |
10% Owner |
– – • |
2021-02-18 |
4 |
S |
$2.95 |
$762,527 |
I/I |
(258,300) |
10,582,117 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-05-19 |
4 |
A |
$16.80 |
$14,499,610 |
I/I |
863,072 |
10,639,992 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-06-30 |
4 |
B |
$26.09 |
$260,900 |
I/I |
10,000 |
10,649,992 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-07-01 |
4 |
B |
$25.70 |
$223,539 |
I/I |
8,698 |
10,658,690 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-07-16 |
4 |
B |
$19.89 |
$397,800 |
I/I |
20,000 |
10,678,690 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-08-21 |
4 |
B |
$16.79 |
$48,691 |
I/I |
2,900 |
10,681,590 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-18 |
4 |
B |
$16.80 |
$8,417 |
I/I |
501 |
10,682,091 |
2.17 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-19 |
4 |
B |
$16.67 |
$531,940 |
I/I |
31,910 |
10,714,001 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-09-22 |
4 |
B |
$16.44 |
$42,547 |
I/I |
2,588 |
10,716,589 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2014-12-31 |
4 |
B |
$19.37 |
$193,700 |
I/I |
10,000 |
10,726,589 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-01-02 |
4 |
B |
$18.43 |
$92,150 |
I/I |
5,000 |
10,731,589 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-01-05 |
4 |
B |
$18.27 |
$54,810 |
I/I |
3,000 |
10,734,589 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-03-09 |
4 |
B |
$17.18 |
$387,993 |
I/I |
22,584 |
10,757,173 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-03-16 |
4 |
B |
$20.55 |
$82,200 |
I/I |
4,000 |
10,761,173 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-04-16 |
4 |
B |
$22.33 |
$44,660 |
I/I |
2,000 |
10,763,173 |
2.25 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2015-04-17 |
4 |
B |
$21.85 |
$196,650 |
I/I |
9,000 |
10,772,173 |
2.25 |
- |
|
637 Records found
|
|
Page 20 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
